Top View
- FAT Mass Standarized Mean Differences
- Supplement Ii to the Japanese Pharmacopoeia Seventeenth Edition
- Pregnenolone Sulfate: from Steroid Metabolite to TRP Channel Ligand
- Activation of Sigma-1 Receptor Chaperone in the Treatment of Neuropsychiatric Diseases and Its Clinical Implication
- Novel Modulation of Adenylyl Cyclase Type 2 Jason Michael Conley Purdue University
- Small-Cell Lung Cancer Growth Inhibition: Synergism Between NMDA Receptor Blockade and Chemotherapy
- PDF (Volume 1)
- (12) Patent Application Publication (10) Pub. No.: US 2016/0015649 A1 Chen Et Al
- Effects of Dehydroepiandrosterone on Cognition: an Electrophysiological Approach
- (12) Patent Application Publication (10) Pub. No.: US 2015/0126612 A1 Went Et Al
- A Single-Channel Mechanism for Pharmacological Potentiation of Glun1/Glun2a NMDA Receptors Received: 2 December 2016 Divyan A
- The Impact of Psychostimulant Administration During Development on Adult Brain Functions Controlling Motivation, Impulsivity and Cognition
- [18F]GE-179 Brain Signal Does Not Show NMDA-Specific Modulation
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Tuesday, December 14 Poster Session II
- Glutamate and Its Receptors As Therapeutic Targets for Migraine
- Customs Tariff - Schedule
- 1 Evaluation of 11C‐Me‐NB1 As a Potential PET Radioligand For
- Molecular Brain Biomed Central
- General Information
- Lower Levels of Dehydroepiandrosterone Sulfate Are Associated with More Advanced Liver Fibrosis in Chronic Hepatitis C
- Customs Tariff - Schedule Xxi - 1
- Memantine Treatment Reduces the Incidence of Flaccid Paralysis in A
- Inhibition of G Protein-Activated Inwardly Rectifying K+ Channels By
- (12) Patent Application Publication (10) Pub. No.: US 2015/0209438A1 Ichinose Et Al
- Psychomotor and Rewarding Properties of the Neurosteroids Dehydroepiandrosterone Sulphate and Androsterone: Effects on Monoamine and Steroid Metabolism
- Target Validation and Pharmacological Characterization of Novel NMDAR Modulators
- Roles of Glutamate Receptors in Parkinson's Disease
- (12) Patent Application Publication (10) Pub. No.: US 2002/0004065 A1 Kanios (43) Pub
- Harmonized Tariff Schedule of the United States (2006) (Rev
- NMDA Receptor Antagonists Attenuate Intrathecal Morphine-Induced
- ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
- (12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
- Opposing Roles of Synaptic and Extrasynaptic NMDA Receptor Signaling in Cocultured Striatal and Cortical Neurons
- Dextromethorphan: an Update on Its Utility for Neurological and Neuropsychiatric Disorders
- United States Patent (19) 11 Patent Number: 6,133,281 Gonzalez-Cadavid Et Al
- NMDA and Glutamate Evoke Excitotoxicity at Distinct Cellular Locations in Rat Cortical Neurons in Vitro
- 1000 Live Plant and Animal Material and Accessories and Supplies 59 1000
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Rank Cmap Name 1 Trichostatin a 2 Piribedil 3 Omeprazole 4 MS-275 5 Penbutolol 6 Calcium Folinate 7 Phthalylsulfathiazole 8 Clop
- Pharmaceutical Appendix to the Tariff Schedule 2
- Dextromethorphan Pre-Review Report
- Neurosteroids Induce Allosteric Effects on the NMDA Receptor
- Ketamine’S Psychotogenic Action and in Schizophrenia Models, by Elizaveta Khlestova, Jon W
- United States Patent (19) 11) Patent Number: 5,656,286 Miranda Et Al
- And NMDAR Antagonists in Murine T- and B-Lymphocyte Function
- Generalization of NMDA-Receptor Antagonists to the Discriminative Stimulus Effects of Κ-Opioid Receptor Agonists U-50,488H, but Not TRK-820 in Rats
- Novel Conjugates of Aminoadamantanes with Carbazole
- 1 Evaluation of 11C‐Me‐NB1 As a Potential PET Radioligand for Measuring Glun2b‐Containing NMDA
- Dopamine and to Have Anticholinergic with Cerebral Infarct on CT.' Using Our Pre
- Potentiation of Nerve Growth Factor-Induced
- Developmental Changes in NMDA Receptor Glycine Affinity And